Skip the primary navigation if you do not want to read it as the next section.
Skip the main content if you do not want to read it as the next section.
Lacosamide validated as promising therapy for uncontrolled partial-onset seizures
A recent multi-centre study has confirmed earlier study results that 400mg/day of lacosamide provides a good balance of efficacy abd tolerability for patients with uncontrolled partial-onset seizures (POS), and doses of 600mg/day may provide additional benefit for some patients.
Date: 9 March 2010
Source: Science Daily
Link: Science Daily (opens in new window)
